Protocols

New Protocols (0*)

* The protocols may appear repeatedly under different diseases

Updated Protocols (0*)

* The protocols may appear repeatedly under different diseases

Protocols in Revision

Breast Cancer

  • STUDY - GAIN-2 - Pertuzumab 420 / Trastuzumab 6, Breast Cancer, neoadjuvant, cycle 2-4 PID 768 V1.1
  • STUDY - GAIN-2 - Pertuzumab 840 / Trastuzumab 8, Breast Cancer, neoadjuvant, cycle 1 PID 767 V1.1

Multiple Myeloma

  • Bortezomib 1.3 / Cyclophosphamide 900 / Dexamethasone 40, Multiple Myeloma PID 532 V1.2
  • Bortezomib 1.3 / Doxorubicin 9 / Dexamethasone 40, Multiple Myeloma PID 529 V1.2
  • Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
  • Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2